Funding and Research Opportunities
The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:
Notices:
- Request for Comments on the Draft NIH Policy on the Use of a Single Institutional Review Board for Multi-Site Research
- (NOT-OD-15-026) Office of the Director, NIH
- Reminder for the Extramural Scientific Community: Implementation of the Genomic Data Sharing Policy Begins January 25, 2015
- (NOT-OD-15-027) Office of the Director, NIH
- Notice of Office of Laboratory Animal Welfare Policy on Shared Animal Welfare Concerns
- (NOT-OD-15-028) Office of the Director, NIH
- NIH Modification to Guidance on Marking Changes in Resubmission Applications
- (NOT-OD-15-030) Office of the Director, NIH
- Update: New Biographical Sketch Format Required for NIH and AHRQ Grant Applications Submitted for Due Dates on or After May 25, 2015
- (NOT-OD-15-032) Office of the Director, NIH
- Notice of NHGRI Participation in PA-14-015 “Ruth L. Kirschstein NRSA Institutional Research Training Grants (Parent T32)” and Establishment of New Training Program in the Ethical, Legal and Social Implications of Genetic and Genomic Research
- (NOT-HG-15-004)
- National Human Genome Research Institute
- Notice of Additional Due Date and Correction for RFA-HG-14-005 “Revisions to Add Biomedical Big Data Training to Active Institutional Training Grants (T32)”
- (NOT-HG-15-009)
- National Human Genome Research Institute
- Notice of Change to Instructions for Senior/Key Personnel in the Overall and Project Components of PAR-13-316 “NHLBI Program Project Applications (P01)”
- (NOT-HL-14-242)
- National Heart, Lung, and Blood Institute
- Request for Information (RFI): Challenges and Opportunities for Exploring and Understanding the Epitranscriptome
- (NOT-RM-15-007)
- NIH Roadmap Initiatives
Requests for Applications:
- Human Cellular Models for Predicting Individual Responses to Cystic Fibrosis Transmembrane Conductance Regulator- Directed Therapeutics (R41)
- (RFA-HL-15-026)
- National Heart, Lung, and Blood Institute
- Application Receipt Date(s): February 9, 2015 and November 9, 2015
- Human Cellular Models for Predicting Individual Responses to Cystic Fibrosis Transmembrane Conductance Regulator- Directed Therapeutics (R43/R44)
- (RFA-HL-15-027)
- National Heart, Lung, and Blood Institute
- Application Receipt Date(s): February 9, 2015; November 9, 2015; and November 9, 2016